PGK1 and familial dilated cardiomyopathy: Treatment with QDYXD significantly reduced the expression levels of PGK1 (p < 0.05), HIF1A (p < 0.001), and LDHA (p < 0.01) in contrast to the DCM group (Figures 9a, 9b, and 9c).